Seaman H - Search Results

1

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 2. The Women's Health Initiative: estrogen plus progestogen.

Shapiro S, Farmer RD, Mueck AO, Seaman H, Stevenson JC. Shapiro S, et al. Among authors: seaman h. J Fam Plann Reprod Health Care. 2011 Jul;37(3):165-72. doi: 10.1136/jfprhc-2011-0090. Epub 2011 Jun 2. J Fam Plann Reprod Health Care. 2011. PMID: 21642264 Free article.

2

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: Part 1. The Collaborative Reanalysis.

Shapiro S, Farmer RD, Seaman H, Stevenson JC, Mueck AO. Shapiro S, et al. Among authors: seaman h. J Fam Plann Reprod Health Care. 2011 Apr;37(2):103-9. doi: 10.1136/jfprhc.2011.0078. J Fam Plann Reprod Health Care. 2011. PMID: 21454266 Free article.

3

Does hormone replacement therapy cause breast cancer? An application of causal principles to three studies: part 3. The Women's Health Initiative: unopposed estrogen.

Shapiro S, Farmer RD, Mueck AO, Seaman H, Stevenson JC. Shapiro S, et al. Among authors: seaman h. J Fam Plann Reprod Health Care. 2011 Oct;37(4):225-30. doi: 10.1136/jfprhc-2011-0091. Epub 2011 Jun 2. J Fam Plann Reprod Health Care. 2011. PMID: 21642263 Free article.

4

Venous thromboembolism and cyproterone acetate in men with prostate cancer: a study using the General Practice Research Database.

Seaman HE, Langley SE, Farmer RD, de Vries CS. Seaman HE, et al. BJU Int. 2007 Jun;99(6):1398-403. doi: 10.1111/j.1464-410X.2007.06859.x. BJU Int. 2007. PMID: 17537215

5

The risk of venous thromboembolism in women prescribed cyproterone acetate in combination with ethinyl estradiol: a nested cohort analysis and case-control study.

Seaman HE, de Vries CS, Farmer RD. Seaman HE, et al. Hum Reprod. 2003 Mar;18(3):522-6. doi: 10.1093/humrep/deg120. Hum Reprod. 2003. PMID: 12615818

6

Venous thromboembolism associated with cyproterone acetate in combination with ethinyloestradiol (Dianette): observational studies using the UK General Practice Research Database.

Seaman HE, de Vries CS, Farmer RD. Seaman HE, et al. Pharmacoepidemiol Drug Saf. 2004 Jul;13(7):427-36. doi: 10.1002/pds.896. Pharmacoepidemiol Drug Saf. 2004. PMID: 15269926

7

Differences in the use of combined oral contraceptives amongst women with and without acne.

Seaman HE, de Vries CS, Farmer RD. Seaman HE, et al. Hum Reprod. 2003 Mar;18(3):515-21. doi: 10.1093/humrep/deg090. Hum Reprod. 2003. PMID: 12615817

8

The risk of liver disorders in women prescribed cyproterone acetate in combination with ethinyloestradiol (Dianette): a nested case-control study using the GPRD.

Seaman HE, de Vries CS, Farmer RD. Seaman HE, et al. Pharmacoepidemiol Drug Saf. 2003 Oct-Nov;12(7):541-50. doi: 10.1002/pds.857. Pharmacoepidemiol Drug Saf. 2003. PMID: 14558177

9

The risk of liver damage associated with minocycline: a comparative study.

Seaman HE, Lawrenson RA, Williams TJ, MacRae KD, Farmer RD. Seaman HE, et al. J Clin Pharmacol. 2001 Aug;41(8):852-60. doi: 10.1177/00912700122010753. J Clin Pharmacol. 2001. PMID: 11504273

10

Liver damage associated with minocycline use in acne: a systematic review of the published literature and pharmacovigilance data.

Lawrenson RA, Seaman HE, Sundström A, Williams TJ, Farmer RD. Lawrenson RA, et al. Among authors: seaman he. Drug Saf. 2000 Oct;23(4):333-49. doi: 10.2165/00002018-200023040-00006. Drug Saf. 2000. PMID: 11051220

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

41 results

Search Page

Filters